跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-FELODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-FELODIPINE
Authorized
STANDARD
APO-FELODIPINE
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e380b10ae40346bc
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
e380b10ae40346bc
Drug Approval Canada Name
APO-FELODIPINE
Product Name
APO-FELODIPINE
Status
Marketed
Status Date
2016-04-22
Original Market Date
2016-04-22
Din
02452367
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA02 FELODIPINE
Atc Name
c 08 ca 02
Aig Number
0121733003
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
FELODIPINE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e380b10ae40346bc
Type
Standard
Back to Health Canada Approvals